QA: REVELATION BIOSCIENCES INC. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001810560_2023_REVELATION_BIOSCIENCES_INC.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001810560, REVELATION BIOSCIENCES INC.

  xvar xval
0 AssetsCurrent 5,413,282
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 90,133
3 remainder_Assets 0
4 LiabilitiesCurrent 4,450,962
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 5,487,111
9 ResearchAndDevelopmentExpense 5,377,400
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 34,962
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 5,503,415
1 Liabilities 4,450,962
2 Expenses 10,864,511
3 Revenues 0
4 StockholdersEquity 1,052,453
5 NetIncome -10,829,549
6 ComprehensiveNetIncome -10,829,549
7 BaseVar 10,426,925
8 EconomicCapitalRatio -1.81

Edgar->Model Mapping

Feature Distribution

Change over Time